Intended Use

The CT Laser Mammography is an innovative device that can image the human breast to detect angiogenesis which may be an early indicator for cancer.

View CTLM® At a Glance in the following languages:

ENGLISH    ROMANIAN   GERMAN   BULGARIAN

The Computed Tomography Laser Mammography (CTLM) Model 1020 is an imaging device that is intended to provide the physician with physiological and clinical information, obtained non-invasively and without the use of ionizing radiation. The CTLM Model 1020 produces 3-dimensional, coronal, sagittal, and axial cross-sectional images that display the distribution of hemoglobin within the internal structure of the breast. When interpreted by a trained physician, those images provide information that can be useful in diagnostic determination. The CTLM is a dedicated breast imaging system intended to be used as an adjunct to conventional breast screening methods.

The CTLM is unique because it uses no x-radiation—only laser light—to create a 3D image. Unlike x-ray mammography, the CTLM never compresses or even touches the breast making the entire exam easy and painless.

IDSI will be applying for FDA approval to sell and market the device in the USA. In the meantime we are marketing the product in many other countries where approvals have already been granted.

Our “intended use” will support our premise that CT Laser Mammography is designed to be an adjunct to conventional breast imaging methods to provide additional information that may be useful in making a diagnosis.

In the future, we believe laser optical breast scanning may be a primary method of diagnostic imaging response to therapy and other applications.

Please review the current CTLM distribution program provided by LEBADA USA, Inc., a Florida / USA Corporation.

LEBADA USA is the Exclusive Distributor for Computer Tomography Laser Mammography (CTLM®) in the following European countries: